Literature DB >> 9285348

Hemodynamic simulations and computer-aided designs of graft-artery junctions.

M Lei1, C Kleinstreuer, J P Archie.   

Abstract

Severe occlusion of graft-artery junctions due to restenosis, e.g., excessive tissue overgrowth and renewed plaque formation, may occur within a few months or years after bypass surgery. Our hypothesis is that nonuniform hemodynamics, represented by large sustained wall shear stress gradients, trigger abnormal biological processes leading to rapid restenosis and hence early graft failure. In turn, this problem may be significantly mitigated by designing graft-artery bypass configurations for which the wall shear stress gradient (WSSG) is approximately zero and hence nearly uniform hemodynamics are achieved. Focusing on the distal end of several femoral artery bypass junctions, a validated finite volume code has been used to compute the transient three-dimensional velocity vector fields and its first and second surface derivatives in order to test the idea. Specifically, it is shown that the Taylor patch, which generates higher patency rates than standard end-to-side anastomoses, exhibits lower WSSG levels than standard configurations, and that further geometric design improvements reduce the WSSG in magnitude and local extent even more.

Entities:  

Mesh:

Year:  1997        PMID: 9285348     DOI: 10.1115/1.2796099

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN: 0148-0731            Impact factor:   2.097


  2 in total

1.  Numerical Simulation of Physiological Blood Flow in 2-way Coronary Artery Bypass Grafts.

Authors:  Aike Qiao; Youjun Liu; Siyang Li; Hu Zhao
Journal:  J Biol Phys       Date:  2005-05       Impact factor: 1.365

2.  Numerical analysis of the impact of flow rate, heart rate, vessel geometry, and degree of stenosis on coronary hemodynamic indices.

Authors:  Zbigniew Malota; Jan Glowacki; Wojciech Sadowski; Marcin Kostur
Journal:  BMC Cardiovasc Disord       Date:  2018-06-28       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.